Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo

GLIA

Volumn 54, Issue 8, 2006, Pages 861-872

  Dijkstra, I M ^a   De Haas, A H ^a   Brouwer, N ^a   Boddeke, H W G M ^a   Biber, Knut ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Antigen presentation; Dendritic cell; LPS treatment; Neuroimmunology; Ovalbumin

Indexed keywords

ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR7; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RODENT;

ANIMALS; ANIMALS, NEWBORN; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS; CHEMOTAXIS; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLIOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS II; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; OVALBUMIN; PHAGOCYTOSIS; RECEPTORS, CHEMOKINE;

EID: 33750538482     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20426     Document Type: Article

References (73)

1. Aloisi F. 2001. Immune function of microglia. Glia 36:165-179.
2. Aloisi F, Ria F, Penna G, Adorini L. 1998. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160:4671-4680.
3. Alt C, Laschinger M, Engelhardt B. 2002. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the bloodbrain barrier suggests their involvement in G- protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur J Immunol 32:2133-2144.
4. Amor S, O'Neill JK, Morris MM, Smith RM, Wraith DC, Groome N, Travers PJ, Baker D. 1996. Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H2Ag7) mice share an amino acid motif. J Immunol 156:3000-3008.
5. Asensio VC, Campbell IL. 1999. Chemokines in the CNS: Plurifunctional mediators in diverse states. Trends Neurosci 22:504-512.
6. Babcock AA, Kuziel WA, Rivest S, Owens T. 2003. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23:7922-7930.
7. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y-J, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811.
8. Becher B, Prat A, Antel JP. 2000. Brain-immune connection: Immunoregulatory properties of CNS-resident cells. Glia 29:293-304.
9. Bechmann I, Nitsch R. 1997. Astrocytes and microglial cells incorporate degenerating fibers following entorhinal lesion: A light, confocal, and electron microscopical study using a phagocytosis-dependent labeling technique. Glia 20:145-154.
10. Biber K, Klotz KN, Berger M, Gebicke-Harter PJ, van Calker D. 1997. Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression. J Neurosci 17:4956-4964.
11. Biber K, Sauter A, Brouwer N, Copray SC, Boddeke HW. 2001. Ischemia-induced neuronal expression of the microglia attracting chemokine secondary lymphoid-tissue chemokine (SLC). Glia 34:121-133.
12. Biber K, Zuurman MW, Dijkstra IM, Boddeke HW. 2002. Chemokines in the brain: Neuroimmunology and beyond. Curr Opin Pharmacol 2:63-68.
13. Brinker T, Ludemann W, Berens vR, Samii M. 1997. Dynamic properties of lymphatic pathways for the absorption of cerebrospinal fluid. Acta Neuropathol (Berl) 94:493-498.
14. Brouwer N, Zuurman MW, Wei T, Ransohoff RM, Boddeke HW, Biber K. 2004. Induction of glial L-CCR mRNA expression in spinal cord and brain in experimental autoimmune encephalomyelitis. Glia 46:84-94.
15. Campbell JJ, Bowman EP, Murphy K, Youngman KR, Siani MA, Thompson DA, Wu L, Zlotnik A, Butcher EC. 1998. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7. J Cell Biol 141:1053-1059.
16. + T cells into the central nervous system by professional antigen-presenting cells. Am J Pathol 154:481-494.
17. Chan A, Seguin R, Magnus T, Papadimitriou C, Toyka KV, Antel JP, Gold R. 2003. Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: Termination of CNS; autoimmune inflammation and modulation by interferon-β. Glia 48:231-242.
18. Chan VW, Kothakota S, Rohan MC, Panganiban-Lustan L, Gardner JP, Wachowicz MS, Winter JA, Williams LT. 1999. Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells. Blood 93:3610-3616.
19. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
20. Columba-Cabezas S, Serafini B, Ambrosini E, Aloisi F. 2003. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: Implications for the maintenance of chronic neuroinflammation. Brain Pathol 13:38-51.
21. Daro E, Pulendran B, Brasel K, Teepe M, Pettit D, Lynch DH, Vremec D, Robb L, Shortman K, McKenna HJ, Maliszewski CR, Maraskovsky E. 2000. Polyethylene glycol-modified GM-CSF expands CD11b (high)-CD11c(high) but not CD11b(low)CD11c(high) murine dendritic cells in vivo: A comparative analysis with Flt3 ligand. J Immunol 165:49458.
22. de Jong EK, Dijkstra IM, Hensens M, Brouwer N, van Amerongen M, Liem RSB, Boddeke HWMG, Biber K. 2005. Vesicle-mediated transport and release of CCL21 in endangered neurons: A possible explanation for microglia activation remote from a primary lesion. J Neurosci 25:7548-7557.
23. de Vos AF, van Meurs M, Brok HP, Boven LA, Hintzen RQ, Van dV, Ravid R, Reusing S, Boon L, 't Hart BA, Laman JD. 2002. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol 169:5415-5423.
24. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Ait-Yahia S, Briere F, Zlotnik A, Lebecque S, Caux C. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188:373-386.
25. Dijkstra IM, Hulshof S, Van dV, Boddeke HW, Biber K. 2004. Cutting edge: Activity of human adult microglia in response to CC chemokine ligand 21. J Immunol 172:2744-2747.
26. Ebert LM, Schaerli P, Moser B. 2005. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol 42:799-809.
27. Fischer HG, Reichmann G. 2001. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol 166:2717-2726.
28. Giunti D, Borsellino G, Benelli R, Marchese M, Capello E, Valle MT, Pedemonte E, Noonan D, Albini A, Bernardi G, Mancardi GL, Battistini L, Uccelli A. 2003. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J Leukoc Biol 73:584-590.
29. Glabinski AR, Ransohoff RM. 1999. Chemokines and chemokine receptors in CNS pathology. J Neurovirol 5:3-12.
30. Greter M, Heppner FL, Lemos MP, Odermatt BM, Goebels N, Laufer T, Noelle RJ, Becher B. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 11:328-334.
31. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 95:258-263.
32. Hanisch UK. 2002. Microglia as a source and target of cytokines. Glia 40:140-155.
33. Harling-Berg CJ, Park TJ, Knopf PM. 1999. Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation. J Neuroimmunol 101:111-127.
34. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hovelmeyer N, Waisman A, Rulicke T, Prinz M, Priller J, Becher B, Aguzzi A. 2005. Experimental autoimmune encephalomyelitis repressed by microgial paralysis. Nat Med 11:146-152.
35. Hermann DM, Mies G, Hata R, Hossmann KA. 2000. Microglial and astrocytic reactions prior to onset of thalamic cell death after traumatic lesion of the rat sensorimotor cortex. Acta Neuropathol (Berl) 99:147-153.
36. Hirasawa T, Ohsawa K, Imai Y, Ondo Y, Akazawa C, Uchino S, Kohsaka S. 2005. Visualization of microglia in living tissues using Ibk1-EGFP transgenic mice. J Neurosci Res 81:357-362.
37. Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S. 1996. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biophys Biochem Res Commun 224:855-862.
38. Jeannin P, Magistrelli G, Herbault N, Goetsch L, Godefroy S, Charbonnier P, Gonzalez A, Delneste Y. 2003. Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organs. Eur J Immunol 33:326-333.
39. Karman J, Ling C, Sandor M, Fabry Z. 2004. Dendritic cells in the initiation of immune responses against central nervous system-derived antigens. Immunol Lett 92:107-115.
40. Kellermann SA, Hudak S, Oldham EB, Liu YJ, McEvoy LM. 1999. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3β are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J Immunol 162:3859-3864.
41. Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM, Hartung HP. 2002. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: A central role for IP-10. Brain 125:823-834.
42. Kivisakk P, Mahad DJ, Callahan MK, Sikora K, Trebst C, Tucky B, Wujek J, Ravid R, Staugaitis SM, Lassmann H, Ransohoff RM. 2004. Expression of CCR7 in multiple sclerosis: Implications for CNS immunity. Ann Neurol 55:627-638.
43. Ling C, Sandor M, Fabry Z. 2003. In situ processing and distribution of intracerebrally injected OVA in the CNS. J Neuroimmunol 141:90-98.
44. Lira SA. 2005. A passport into the lymph node. Nat Immunol 6:866-868.
45. -/- mice with experimental autoimmune encephalomyelitis. J Immunol 176:4399-4409.
46. T method. Methods 25:402-408.
47. Mack CL, Vanderlugt-Castaneda CL, Neville KL, Miller SD. 2003. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis. J Neuroimmunol 144:68-79.
48. Magnus T, Chan A, Grauer O, Toyka KV, Gold R. 2001. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J Immunol 167:5004-5010.
49. McMahon EJ, Bailey SL, Miller SD. 2006. CNS dendritic cells: Critical participants in CNS inflammation? Neurochem Int 49:195-203.
50. McMahon EJ, Bailey SL, Vanderlugt-Castenada C, Waldner H, Miller SD. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 11:335-339.
51. Mertsch K, Hanisch UK, Kettenmann H, Schnitzer J. 2001. Characterization of microglial cells and their response to stimulation in an organotypic retinal culture system. J Comp Neurol 431:217-227.
52. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA. 2000. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:145-176.
53. Pashenkov M, Soderstrom M, Link H. 2003. Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation. J Neuroimmunol 135:154-160.
54. Phillips MJ, Needham M, Weller RO. 1997. Role of cervical lymph nodes in autoimmune encephalomyelitis in the Lewis rat. J Pathol 182:457-464.
55. - current and chemotaxis in murine microglia. J Immunol 168:3221-3226.
56. Reichmann G, Schroeter M, Jander S, Fischer HG. 2002. Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain. J Neuroimmunol 129:125-132.
57. Rossi D, Zlotnik A. 2000. The biology of chemokines and their receptors. Annu Rev Immunol 18:217-242.
58. Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, Julkunen I, Forster R, Burgstahler R, Lipp M, Lanzavecchia A. 1999. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 29:1617-1625.
59. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28:2760-2769.
60. Santambrogio L, Belyanskaya SL, Fischer FR, Cipriani B, Brosnan CF, Ricciardi-Castagnoli P, Stern LJ, Strominger JL, Riese R. 2001. Developmental plasticity of CNS microglia. Proc Natl Acad Sci USA 98:6295-6300.
61. Saura J, Tusell JM, Serratosa J. 2003. High-yield isolation of murine microglia by mild trypsinization. Glia 44:183-189.
62. Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, Kiefer R. 2003. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: A study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 183:25-33.
63. Schmitt AB, Buss A, Breuer S, Brook GA, Pech K, Martin D, Schoenen J, Noth J, Love S, Schroder JM, Kreutzberg GW, Nacimiento W. 2000. Major histocompatibility complex class II expression by activated microglia caudal to lesions of descending tracts in the human spinal cord is not associated with a T cell response. Acta Neuropathol (Berl) 100:528-536.
64. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Capello E, Mancardi GL, Aloisi F. 2006. Dendritic cells in multiple sclerosis lesions: Maturation stage, myelin uptake, and interaction with proliferating T cells. J Neuropathol Exp Neurol 65:124-141.
65. Sørensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103:807-815.
66. Sørensen TL, Trebst C, Kivisäkk P, Klaege KL, Majmudar A, Ravid R, Lassmann H, Olsen DB, Strieter RM, Ransohoff RM, Sellebjerg F. 2002. Multiple sclerosis: A study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system. J Neuroimmunol 127:59-68.
67. Sozzani S, Allavena P, D'Amico G, Luini W, Bianchi G, Kataura M, Imai T, Yoshie O, Bonecchi R, Mantovani A. 1998. Differential regulation of chemokine receptors during dendritic cell maturation: A model for their trafficking properties. J Immunol 161:1083-1086.
68. Stoll G, Jander S. 1999. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 58:233-247.
69. Streit WJ, Walter SA, Pennell NA. 1999. Reactive microgliosis. Prog Neurobiol 57:563-581.
70. Trebst C, Staugaitis SM, Tucky B, Wei T, Suzuki K, Aldape KD, Pardo CA, Tronccoso J, Lassmann H, Ransohoff RM. 2003. Chemokine receptors on infiltrating leuckocytes in inflammatory pathologies of the central nervous system (CNS). Neuropathol Appl Neurobiol 29:584-595.
71. Villadangos JA, Schnorrer P, Wilson NS. 2005. Control of MHC class II antigen presentation in dendritic cells: A balance between creative and destructive forces. Immunol Rev 207:191-205.
72. Willimann K, Legler DF, Loetscher M, Roos RS, Delgado MB, Clark-Lewis I, Baggiolini M, Moser B. 1998. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur J Immunol 28:2025-2034.
73. Xia MQ, Bacskai BJ, Knowles RB, Qin SX, Hyman BT. 2000. Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: In vitro ERK1/2 activation and role in Alzheimer's disease. J Neuroimmunol 108:227-235.